Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Flepp

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
European Journal of Immunology|February 17, 1998
Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV CohortR A Morawetz, G P Rizzardi, D Glauser, et al.
HIV Medicine|December 19, 2019
Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017B Hampel, K Kusejko, R D Kouyos, et al.
BMC Infectious Diseases|September 28, 2011
High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of diseaseJörg Schüpbach, Leslie R Bisset, Stephan Regenass, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
European Journal of Immunology|February 17, 1998
Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV CohortR A Morawetz, G P Rizzardi, D Glauser, et al.
HIV Medicine|December 19, 2019
Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017B Hampel, K Kusejko, R D Kouyos, et al.
BMC Infectious Diseases|September 28, 2011
High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of diseaseJörg Schüpbach, Leslie R Bisset, Stephan Regenass, et al.
Pageof 7